ENDOCARDIAL INVOLVEMENT IN SYSTEMIC AUTOIMMUNE DISEASES: PATHOPHYSIOLOGY, CLINICAL MANIFESTATIONS, AND MANAGEMENT
Authors:
- Karol SzyprowskiKSKarol Szyprowski
- Jakub SkrzypekJSJakub Skrzypek
- Natalia FidutNFNatalia Fidut
- Kamila ZiołoKZKamila Zioło
- Weronika ZarzyckaWZWeronika Zarzycka
- Maciej KisielewskiMKMaciej Kisielewski
- Julia WawerskaJWJulia Wawerska
- Weronika WrzosekWWWeronika Wrzosek
- Bartosz OklińskiBOBartosz Okliński
- Mateusz ZugajMZMateusz Zugaj
Open Access
- 30 June 2026
- journal article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
Abstract
Purpose: The manuscript aims to highlight the clinical significance of Libman-Sacks endocarditis (LSE) in patients with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). It emphasizes the importance of early diagnosis and multidisciplinary management to prevent severe cardiac complications and improve patient outcomes. Methodology: A comprehensive review of recent literature and case studies was conducted, focusing on the pathogenesis, clinical presentation, diagnostic approaches, and management strategies for LSE in SLE and APS patients. The article synthesizes evidence from published research, including echocardiographic findings, laboratory markers, and therapeutic interventions Findings: LSE is frequently underdiagnosed due to its subtle clinical manifestations. Echocardiography remains the gold standard for detection, revealing characteristic vegetations on heart valves. The manuscript identifies a strong association between LSE and thromboembolic events in SLE/APS patients. Multidisciplinary collaboration among cardiologists, rheumatologists, hematologists, and cardiac surgeons is crucial for optimal management. Anticoagulation and immunosuppressive therapy are central to treatment, with surgical intervention reserved for severe cases. Conclusions: Early recognition and coordinated care are essential to reduce morbidity and mortality associated with LSE in SLE and APS. The article advocates for routine cardiac screening in high-risk patients and underscores the need for further research to refine diagnostic and therapeutic protocols.Keywords
This publication has 19 references indexed in Scilit:
- Complement involvement in antiphospholipid syndromeImmunology Letters, 2026
- Catastrophic antiphospholipid syndrome with eosinophilia mimicking hypereosinophilic syndromes with disseminated intravascular coagulation: a case reportJournal of Medical Case Reports, 2026
- Catastrophic Antiphospholipid Syndrome: A Rare but Life‐Threatening Thrombotic Storm—A Case Report and Literature ReviewCase Reports in Rheumatology, 2026
- Severe Aortic Stenosis and Dual Valve VegetationsJACC: Case Reports, 2025
- Systemic Lupus Erythematosus With Catastrophic APS and Libman–Sacks Endocarditis in a Patient With Autoimmune Hemolytic Anemia: A Case ReportClinical Case Reports, 2025
- Libman-Sacks endocarditis of the mitral valve as a first presentation of systemic lupus erythematosusJournal of Surgical Case Reports, 2025
- Catastrophic antiphospholipid syndrome following surgery for Libman–Sacks endocarditis: A case report and literature reviewJournal of Cardiothoracic Surgery, 2025
- Multimodality Imaging and Multidisciplinary Diagnosis of Hydroxychloroquine Cardiotoxicity With CMD and Libman-Sacks EndocarditisJACC: Case Reports, 2025
- Spontaneous coronary artery dissection and valvular disease revealing an antiphospholipid syndrome in a young woman: Case reportRadiology Case Reports, 2024
- MULTI-DISCIPLINARY APPROACH IN LIBMAN-SACKS ENDOCARDITISJACC, 2024